Skip to main content

Table 1 Comparison of clinical characteristics between Malaysian renal transplant recipients who developed NODAT and those without NODAT at 1-year post- transplant

From: Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia

  All patients
(n = 168)
N (%) or
mean ± SD
NODAT (n = 29)
N (%) or mean ± SD
NON-NODAT (n = 139)
N (%) or
mean ± SD
p
Gender     0.70
 - Male 98 (58) 16 (6) 82 (84)  
 - Female 70 (42) 13 (19) 57 (81)  
Age at transplant 34.8 (12.1) 39.3 ± 13.4 33.9 ± 11.8 0.03
Ethnicities     0.84
 - Malay 34 (20) 5 (15) 29 (85)  
 - Chinese 115 (69) 20 (17) 95 (83)  
 - Indian 19 (11) 4 (11) 15 (79)  
Primary kidney disease     0.20
 - Glomerulonephritis 51 (30) 9 (18) 42 (82)  
 - Hypertension 19 (11) 6 (32) 13 (68)  
 - Others 98 (59) 14 (14) 84 (86)  
Type of donor     0.76
 - Living related 71 (45) 11 (15) 60 (85)  
 - Living non-related 20 (42) 3 (15) 17 (85)  
 - Cadaveric 77 (12) 15 (20) 62 (80)  
Place of transplant     0.05
 - Local 114 (67) 15 (13) 98 (87)  
 - Overseas 54 (32) 14 (26) 40 (74)  
Types of calcineurin inhibitors     0.66
 - Cyclosporine 90 (54) 15 (17) 75 (83)  
 - Tacrolimus 67 (40) 11 (16) 56 (84)  
 - Both 11 (6) 3 (27) 8 (73)  
Duration of dialysis (month) 33.0 (40.5) 23.1 ± 23.5 35.5 ± 43.3 0.09
BMI (kg/m2) 21.3 (4.6) 21.9 ± 4.6 21.1 ± 4.4 0.35
Levels of creatinine (μmol/L) 127 (122.6) 112.24 ± 34.2 130.11 ± 99.1 0.68
Fasting blood glucose (μmol/L) 5.5 (1.4) 6.5 ± 1.8 5.2 ± 0.7 < 0.0001
Average daily dose of cyclosporine (mg/kg) 295.4 (116.5) 328.8 ± 125.8 280.6 ± 92.3 0.15
Average daily dose of tacrolimus (mg/day) 7.5 (3.4) 7.5 ± 3.1 7.8 ± 2.4 0.55
Average daily dose of prednisolone (mg/day) 15.8 (4.4) 16.2 ± 2.6 15.8 ± 2.6 0.45